Vemurafenib-induced cardiac tamponade: a rare but potentially life-threatening complication

J Clin Oncol. 2013 Jul 20;31(21):e364-6. doi: 10.1200/JCO.2012.47.0104. Epub 2013 Jun 10.

Authors

Kathleen M Mahoney¹, Allison Ackerman, Daniel C Cho, David F McDermott, Toni Peters, Michael B Atkins

Affiliation

¹ Division of Hematology and Oncology, Beth Israel Deaconess Medical Center, 330 Brookline Ave, Boston, MA 02215, USA. kmmah5@bidmc.harvard.edu

PMID: 23752114
DOI: 10.1200/JCO.2012.47.0104

No abstract available

Publication types

Case Reports

MeSH terms

Antineoplastic Agents / adverse effects
Antineoplastic Agents / therapeutic use
Cardiac Tamponade / chemically induced*
Humans
Indoles / adverse effects*
Indoles / therapeutic use
Male
Melanoma / drug therapy
Middle Aged
Prognosis
Sulfonamides / adverse effects*
Sulfonamides / therapeutic use
Vemurafenib

Substances

Antineoplastic Agents
Indoles
Sulfonamides
Vemurafenib